Targeted Protein Degradation (TPD) leverages the cell’s natural degradation system to eliminate disease-causing proteins. Molecular glue technology, in particular, enables the targeting of previously undruggable proteins, expanding the scope of therapeutic intervention. PROTIER Biotech has developed an innovative molecular glue discovery platform.